InvestorsHub Logo
Followers 971
Posts 383010
Boards Moderated 6
Alias Born 06/24/2011

Re: None

Wednesday, 08/07/2019 11:01:49 AM

Wednesday, August 07, 2019 11:01:49 AM

Post# of 4143
$ISBG the Company has frequently commented on the demand growth it has seen in its CBD products segment, ISBG has not discussed its growing home healthcare services segment as a core strategic and operational factor. However, this segment has shown steady and robust top line growth on a sequential month-over-month basis in both total patients and total sales so far in 2019, and the Company expects this trend to continue and potentially accelerate in the months and quarters ahead.

Mr. Williams continued, “Our data and analysis suggests that the home healthcare segment alone will offer up a major contribution to overall top line growth in Q3 and for our full-year fiscal 2019 financial performance. We continue to be very excited about the potential for a further acceleration in the quarters ahead as we gain new patients and margins widen as volume drowns out fixed operating costs.”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.